Literature DB >> 12140777

Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes.

R E Straub1, C J MacLean, Y Ma, B T Webb, M V Myakishev, C Harris-Kerr, B Wormley, H Sadek, B Kadambi, F A O'Neill, D Walsh, K S Kendler.   

Abstract

From our linkage study of Irish families with a high density of schizophrenia, we have previously reported evidence for susceptibility genes in regions 5q21-31, 6p24-21, 8p22-21, and 10p15-p11. In this report, we describe the cumulative results from independent genome scans of three a priori random subsets of 90 families each, and from multipoint analysis of all 270 families in ten regions. Of these ten regions, three (13q32, 18p11-q11, and 18q22-23) did not generate scores above the empirical baseline pairwise scan results, and one (6q13-26) generated a weak signal. Six other regions produced more positive pairwise and multipoint results. They showed the following maximum multipoint H-LOD (heterogeneity LOD) and NPL scores: 2p14-13: 0.89 (P = 0.06) and 2.08 (P = 0.02), 4q24-32: 1.84 (P = 0.007) and 1.67 (P = 0.03), 5q21-31: 2.88 (P= 0.0007), and 2.65 (P = 0.002), 6p25-24: 2.13 (P = 0.005) and 3.59 (P = 0.0005), 6p23: 2.42 (P = 0.001) and 3.07 (P = 0.001), 8p22-21: 1.57 (P = 0.01) and 2.56 (P = 0.005), 10p15-11: 2.04 (P = 0.005) and 1.78 (P = 0.03). The degree of 'internal replication' across subsets differed, with 5q, 6p, and 8p being most consistent and 2p and 10p being least consistent. On 6p, the data suggested the presence of two susceptibility genes, in 6p25-24 and 6p23-22. Very few families were positive on more than one region, and little correlation between regions was evident, suggesting substantial locus heterogeneity. The levels of statistical significance were modest, as expected from loci contributing to complex traits. However, our internal replications, when considered along with the positive results obtained in multiple other samples, suggests that most of these six regions are likely to contain genes that influence liability to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140777     DOI: 10.1038/sj.mp.4001051

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  44 in total

1.  Effects of fingolimod administration in a genetic model of cognitive deficits.

Authors:  D Becker-Krail; A Q Farrand; H A Boger; A Lavin
Journal:  J Neurosci Res       Date:  2016-07-20       Impact factor: 4.164

2.  Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.

Authors:  Katherine H Karlsgodt; Karla Robleto; Heather Trantham-Davidson; Corey Jairl; Tyrone D Cannon; Antonieta Lavin; J David Jentsch
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

3.  Linkage analysis of schizophrenia controlling for population substructure.

Authors:  Tiina Paunio; Ritva Arajärvi; Joseph D Terwilliger; Tero Hiekkalinna; Perttu Haimi; Timo Partonen; Jouko Lönnqvist; Leena Peltonen; Teppo Varilo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

4.  FBXL21 association with schizophrenia in Irish family and case-control samples.

Authors:  Xiangning Chen; Xu Wang; Cuie Sun; Qi Chen; F Anthony O'Neill; Dermot Walsh; Ayman Fanous; Kenneth S Kendler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

5.  Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia?

Authors:  Qi Chen; Xu Wang; Francis A O'Neill; Dermot Walsh; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-16       Impact factor: 4.939

6.  Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.

Authors:  Erika Pedrosa; Radu Stefanescu; Benjamin Margolis; Oriana Petruolo; Yungtai Lo; Karen Nolan; Tomas Novak; Pavla Stopkova; Herbert M Lachman
Journal:  Schizophr Res       Date:  2008-05-27       Impact factor: 4.939

7.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

8.  Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate.

Authors:  Barbara Kremeyer; Jenny García; Hanna Kymäläinen; Naomi Wratten; Gabriel Restrepo; Carlos Palacio; Ana Lucía Miranda; Carlos López; Margarita Restrepo; Gabriel Bedoya; Linda M Brzustowicz; Jorge Ospina-Duque; María Patricia Arbeláez; Andrés Ruiz-Linares
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

9.  DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Gregory J Burrell; Aaron J Krasner; Daniel B Schwartz; Pablo V Gejman
Journal:  Hum Hered       Date:  2007-05-02       Impact factor: 0.444

10.  A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.

Authors:  Jana Strohmaier; Josef Frank; Jens R Wendland; Johannes Schumacher; Rami Abou Jamra; Jens Treutlein; Vanessa Nieratschker; René Breuer; Manuel Mattheisen; Stefan Herms; Thomas W Mühleisen; Wolfgang Maier; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Thomas G Schulze
Journal:  Schizophr Res       Date:  2010-01-18       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.